1. Calcium and blood pressure

   • Norman M. Kaplan

   Editorial Comments Pages: 269 - 274

2. Treatment of hypertension in the elderly

   • W. H. Birkenhäger
   • P. W. de Leeuw
   • J. Staessen

   Editorial Comments Pages: 275 - 279

3. Atherosolerosis and fish oil

   • Matthias Goerig
   • Andreas Habenicht
   • Gotthard Schettler

   Editorial Comments Pages: 281 - 282

4. Marked Q-T prolongation due to encainide therapy

   • William Davies
   • Mohammad Jazayeri
   • Patrick Tchou

   Clinical Studies Pages: 283 - 286

5. Isometric exercise for the evaluation of vasodilatory therapy in severe congestive heart failure

   • Frank F. Hertrich
   • Bernhard R. Winkelmann
   • Hans Leinberger

   Clinical Studies Pages: 287 - 293

6. Allopurinol and reperfusion-induced arrhythmias: Increased protection by simultaneous administration of anti-oxidant enzymes

   • Renata Crome
   • Allan S. Manning

   Experimental Studies Pages: 295 - 304

7. Acute hemodynamic effects of MDL 19205 on conscious dogs with mitral regurgitation

   • Takashi Susawa
   • Yasuki Kihara
   • Chuichi Kawai

   Experimental Studies Pages: 305 - 311

8. Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog

   • J. G. Kingma Jr.
   • D. M. Yellon

   Experimental Studies Pages: 313 - 323

9. Comparison of functional responses of canine coronary artery and saphenous vein

   • Takaaki Isshiki
   • Nobuharu Akatsuka
   • Hiroshi Oka

   Experimental Studies Pages: 325 - 331

10. Unstable angina: Current concepts of medical management

    • Christian W. Hamm
    • Walter Bleifeld

    Practical Therapy Pages: 333 - 339

11. Editor's introduction

    Symposium on Combined Alpha- and Beta Blockade in Angina Pages: 341 - 341

12. Properties of labetalol, a combined α-and β-blocking agent, relevant to the treatment of myocardial ischemia

    • William H. Frishman

    Symposium on Combined Alpha- and Beta Blockade in Angina Pages: 343 - 353

13. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease

    • Robert L. Feldman
    • Xavier E. Prida
    • James A. Hill

    Symposium on Combined Alpha- and Beta Blockade in Angina Pages: 355 - 361

14. Labetalol in normotensive patients with angina pectoris

    • Kim Fox
    • Arshed A. Quyyumi

    Symposium on Combined Alpha- and Beta Blockade in Angina Pages: 363 - 367

15. Role of vasobilation in the antihypertensive and antianginal effects of labetalol: Implications for therapy of combined hypertension and angina

    • Lionel H. Opie

    Symposium on Combined Alpha- and Beta Blockade in Angina Pages: 369 - 376

16. Book review

    BookReview Pages: 377 - 377

17. Announcement

    Announcement Pages: 379 - 380